Los Angeles Capital Management LLC Relay Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 52,770 shares of RLAY stock, worth $211,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,770
Previous 31,890
65.48%
Holding current value
$211,080
Previous $225,000
3.56%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RLAY
# of Institutions
208Shares Held
162MCall Options Held
102KPut Options Held
28.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$112 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$60.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$42.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$35.8 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$32.3 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $481M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...